Pharmaceutical Intermediates and API Market Report

Pharmaceutical Intermediates and API Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Oct 15, 2019
  • PAGES：151
  • REPORT CODE：GMM322333
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Pharmaceutical Intermediates and API market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.4% during the forecast period.

    This report presents the market size and development trends by detailing the Pharmaceutical Intermediates and API market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Pharmaceutical Intermediates and API market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Pharmaceutical Intermediates and API industry and will help you to build a panoramic view of the industrial development.

    Pharmaceutical Intermediates and API Market, By Type:

    • Chiral Building Blocks

    • Achiral Building Blocks

    Pharmaceutical Intermediates and API Market, By Application:

    • Pharmaceutical Companies

    • Research Labs

    • Contract Manufacturing Organizations

    • Other Industries

    Some of the leading players are as follows:

    • GSI Pharmaceuticals.

    • Suntec Corporation

    • Vinchem Inc

    • BASF

    • Abiogen Pharma SPA

    • The WeylChem Group

    • B. Braun Medical Ltd

    • Kopran

    • Amarin Crop

    • B Braun Medical Ltd

    • ZCL Chemicals Ltd

    • CordenPharma

    • DSM Chemicals

    • Kuraray Europe GmbH

    • Summit Pharmaceuticals Europe.

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Pharmaceutical Intermediates and API Market: Technology Type Analysis

    • 4.1 Pharmaceutical Intermediates and API Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Pharmaceutical Intermediates and API Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Chiral Building Blocks

      • 4.3.2 Achiral Building Blocks

    5 Pharmaceutical Intermediates and API Market: Product Analysis

    • 5.1 Pharmaceutical Intermediates and API Product Market Share Analysis, 2018 & 2026

    • 5.2 Pharmaceutical Intermediates and API Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Pharmaceutical Intermediates and API Market: Application Analysis

    • 6.1 Pharmaceutical Intermediates and API Application Market Share Analysis, 2018 & 2026

    • 6.2 Pharmaceutical Intermediates and API Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Pharmaceutical Companies

      • 6.3.2 Research Labs

      • 6.3.3 Contract Manufacturing Organizations

      • 6.3.4 Other Industries

    7 Pharmaceutical Intermediates and API Market: Regional Analysis

    • 7.1 Pharmaceutical Intermediates and API Regional Market Share Analysis, 2018 & 2026

    • 7.2 Pharmaceutical Intermediates and API Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 GSI Pharmaceuticals.

      • 9.1.1 GSI Pharmaceuticals. Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Suntec Corporation

      • 9.2.1 Suntec Corporation Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Vinchem Inc

      • 9.3.1 Vinchem Inc Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 BASF

      • 9.4.1 BASF Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Abiogen Pharma SPA

      • 9.5.1 Abiogen Pharma SPA Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 The WeylChem Group

      • 9.6.1 The WeylChem Group Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 B. Braun Medical Ltd

      • 9.7.1 B. Braun Medical Ltd Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 Kopran

      • 9.8.1 Kopran Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

    • 9.9 Amarin Crop

      • 9.9.1 Amarin Crop Company overview

      • 9.9.2 Financial performance

      • 9.9.3 Product benchmarking

      • 9.9.4 Strategic initiatives

      • 9.9.5 SWOT analysis

    • 9.10 B Braun Medical Ltd

      • 9.10.1 B Braun Medical Ltd Company overview

      • 9.10.2 Financial performance

      • 9.10.3 Product benchmarking

      • 9.10.4 Strategic initiatives

      • 9.10.5 SWOT analysis

    • 9.11 ZCL Chemicals Ltd

      • 9.11.1 ZCL Chemicals Ltd Company overview

      • 9.11.2 Financial performance

      • 9.11.3 Product benchmarking

      • 9.11.4 Strategic initiatives

      • 9.11.5 SWOT analysis

    • 9.12 CordenPharma

      • 9.12.1 CordenPharma Company overview

      • 9.12.2 Financial performance

      • 9.12.3 Product benchmarking

      • 9.12.4 Strategic initiatives

      • 9.12.5 SWOT analysis

    • 9.13 DSM Chemicals

      • 9.13.1 DSM Chemicals Company overview

      • 9.13.2 Financial performance

      • 9.13.3 Product benchmarking

      • 9.13.4 Strategic initiatives

      • 9.13.5 SWOT analysis

    • 9.14 Kuraray Europe GmbH

      • 9.14.1 Kuraray Europe GmbH Company overview

      • 9.14.2 Financial performance

      • 9.14.3 Product benchmarking

      • 9.14.4 Strategic initiatives

      • 9.14.5 SWOT analysis

    • 9.15 Summit Pharmaceuticals Europe.

      • 9.15.1 Summit Pharmaceuticals Europe. Company overview

      • 9.15.2 Financial performance

      • 9.15.3 Product benchmarking

      • 9.15.4 Strategic initiatives

      • 9.15.5 SWOT analysis

     

    The List of Tables and Figures (Totals 71 Figures and 137 Tables)

    • Figure Chiral Building Blocks Pharmaceutical Intermediates and API market, 2015 - 2026 (USD Million)

    • Figure Achiral Building Blocks Pharmaceutical Intermediates and API market, 2015 - 2026 (USD Million)

    • Figure Pharmaceutical Companies market, 2015 - 2026 (USD Million)

    • Figure Research Labs market, 2015 - 2026 (USD Million)

    • Figure Contract Manufacturing Organizations market, 2015 - 2026 (USD Million)

    • Figure Other Industries market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Pharmaceutical Intermediates and API market, by country, 2015 - 2026 (USD Million)

    • Table North America Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

    • Table North America Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

    • Table North America Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

    • Table Canada Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

    • Table Canada Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

    • Table Europe Pharmaceutical Intermediates and API market, by country, 2015 - 2026 (USD Million)

    • Table Europe Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

    • Table Europe Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

    • Table Europe Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

    • Table Germany Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

    • Table Germany Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

    • Table France Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

    • Table France Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

    • Table Italy Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

    • Table Italy Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

    • Table Spain Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

    • Table Spain Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Pharmaceutical Intermediates and API market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

    • Table China Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

    • Table China Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

    • Table Japan Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

    • Table Japan Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

    • Table India Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

    • Table India Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Pharmaceutical Intermediates and API market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

    • Table MEA Pharmaceutical Intermediates and API market, by country, 2015 - 2026 (USD Million)

    • Table MEA Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

    • Table MEA Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

    • Table MEA Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Pharmaceutical Intermediates and API market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Pharmaceutical Intermediates and API market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Pharmaceutical Intermediates and API market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table GSI Pharmaceuticals. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Suntec Corporation Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Vinchem Inc Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table BASF Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Abiogen Pharma SPA Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table The WeylChem Group Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table B. Braun Medical Ltd Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Kopran Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Amarin Crop Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table B Braun Medical Ltd Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table ZCL Chemicals Ltd Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table CordenPharma Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table DSM Chemicals Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Kuraray Europe GmbH Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Summit Pharmaceuticals Europe. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US